An update on targeted therapies in systemic sclerosis based on a systematic review from the last 3 years

por Campochiaro, Corrado, Allanore, Yannick
Publicado 2021

Targeting Costimulatory Pathways in Systemic Sclerosis

por Boleto, Gonçalo, Allanore, Yannick, Avouac, Jérôme
Publicado 2018

The role of antifibrotic therapies in the treatment of systemic sclerosis–associated interstitial lung disease

por Boleto, Gonçalo, Avouac, Jérôme, Allanore, Yannick
Publicado 2022

Scleroderma renal crisis: Case reports and update on critical issues

por Zanatta, Elisabetta, Codullo, Veronica, Allanore, Yannick
Publicado 2021

Treatment of systemic sclerosis: is there any hope for the future?

por Allanore, Yannick, Matucci-Cerinic, Marco, Distler, Oliver
Publicado 2016

Soluble CD163 as a Potential Biomarker in Systemic Sclerosis

por Frantz, Camelia, Pezet, Sonia, Avouac, Jerome, Allanore, Yannick
Publicado 2018

Regulatory T Cells in Systemic Sclerosis

por Frantz, Camelia, Auffray, Cedric, Avouac, Jerome, Allanore, Yannick
Publicado 2018

Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble r...

por Allanore, Yannick, Borderie, Didier, Lemaréchal, Hervé, Ekindjian, Ohvanesse Garabed, Kahan, André
Publicado 2004

Interstitial pneumonia with autoimmune features: a new classification still on the move

por Cavagna, Lorenzo, Gonzalez Gay, Miguel A., Allanore, Yannick, Matucci-Cerinic, Marco
Publicado 2018

Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease

por Truchetet, Marie-Elise, Brembilla, Nicolò C, Montanari, Elisa, Allanore, Yannick, Chizzolini, Carlo
Publicado 2011

Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis

por Allanore, Yannick, Borderie, Didier, Périanin, Axel, Lemaréchal, Hervé, Ekindjian, Ohvanesse Garabed, Kahan, André
Publicado 2005

Linking systemic angiogenic markers to synovial vascularization in rheumatoid arthritis

por Leblond, Agathe, Pezet, Sonia, Trouvin, Anne Priscille, Elhai, Muriel, Gonzalez, Virginie, Allanore, Yannick, Avouac, Jérôme
Publicado 2018

Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features

por Hoffmann-Vold, Anna-Maria, Distler, Oliver, Murray, Baron, Kowal-Bielecka, Otylia, Khanna, Dinesh, Allanore, Yannick
Publicado 2019

Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease

por Al Tabaa, Omar, Ghossan, Roba, Combier, Alice, Steelandt, Alexia, Thomas, Marion, Avouac, Jerome, Allanore, Yannick
Publicado 2023

Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapy

por Leboime, Ariane, Berthelot, Jean-Marie, Allanore, Yannick, Khalil-Kallouche, Lama, Herman, Philippe, Orcel, Philippe, Lioté, Frédéric
Publicado 2009

Clinical characteristics and predictors of gangrene in patients with systemic sclerosis and digital ulcers in the Digital Ulcer Outcome Registry: a prospective, observational cohor...

por Allanore, Yannick, Denton, Christopher P, Krieg, Thomas, Cornelisse, Peter, Rosenberg, Daniel, Schwierin, Barbara, Matucci-Cerinic, Marco
Publicado 2016

Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease

por Avouac, Jérôme, Cauvet, Anne, Steelandt, Alexia, Shirai, Yuichiro, Elhai, Muriel, Kuwana, Masataka, Distler, Oliver, Allanore, Yannick
Publicado 2020

Natural variability in the disease course of SSc-ILD: implications for treatment

por Vonk, Madelon C., Walker, Ulrich A., Volkmann, Elizabeth R., Kreuter, Michael, Johnson, Sindhu R., Allanore, Yannick
Publicado 2021

Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit

por Kakkar, Vishal, Assassi, Shervin, Allanore, Yannick, Kuwana, Masataka, Denton, Christopher P., Khanna, Dinesh, Del Galdo, Francesco
Publicado 2022

Retraction Note: Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis

por Ruzehaji, Nadira, Avouac, Jerome, Elhai, Muriel, Frechet, Maxime, Frantz, Camelia, Ruiz, Barbara, Distler, Joerg H., Allanore, Yannick
Publicado 2023